Pfizer is seeking urgent approval of its US vaccine for children 6 months to 4 years old


Pfizer / BioNTech has announced that it has applied to the United States for approval for the emergency use of its COVID-19 vaccine in children aged six months to four years. This is the first time this has been done for this age group.

If the US Food and Drug Administration (FDA) gives the green light, an extra layer of protection against the new coronavirus will be added, as the virus is particularly prevalent in schools.

– “Early” a declaration of victory over the virus –

The director general of the World Health Organization (WHO) warned yesterday that it was too early for countries to declare victory over COVID-19 or to abandon their efforts to stop the spread of the virus.

“It’s premature for any country to surrender or declare victory,” Tentros Adanom Gebregesous told a news conference, expressing concern about a rise in deaths in most parts of the world.

WHO Chief of Emergency Situations Michael Ryan also expressed fears that some countries may want – due to political pressure – to emulate governments that are already relaxing measures, without taking into account their own situation regarding the health and vaccination coverage.

In France, doctors are divided over the easing of restrictive measures. Some argue that “the circulation of the virus remains extremely high”, while others that the “benefit-risk balance” tends to favor the principle of returning to a normal life.

All the news.

Follow on Google News
and be the first to know all the news


You May Also Like

Recommended for you